Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02269579
Title Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic Impairment
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Celator Pharmaceuticals
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Ronald Reagan UCLA Medical Center Los Angeles California 90095 United States Details
Shands Cancer Hospital @ University of Florida Gainesville Florida 32610 United States Details
Franciscan St. Francis Health Indianapolis Indiana 46237 United States Details
John Theurer Cancer Center @ Hackensack Medical University Medical Center Hackensack New Jersey 07601 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from for the field